Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Influx Healthtech Limited (NSE: INFLUX), ISIN INE0MYZ01012 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
INFLUX last traded at ₹256.00 (-0.78%), with a 52-week range of ₹170.75 to ₹315.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 73.53%, FIIs 0.41%, DIIs 7.33%, mutual funds 0.00%.
EquiSense Score (ECS): 85/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.